Clinical Lab Reimbursement Experts Discuss PAMA Pressure and Leaving Money on the Table
Attorney Danielle Tangorre and TELCOR’s Darla Wanitschke answered questions during webinar
Already a member? Log in here
Reimbursement-lir
Subscribe today for access to
Articles and Reports
What New Prior Authorization Metrics Mean for Clinical Labs
KFF looks into payer claims denials, which continue to be scrutinized
Already a member? Log in here
Software as a Medical Service, or SaMS, Takes Spotlight in New CMS Proposal
Clinical labs have until Aug. 31 to submit public comments about the anticipated changes
Already a member? Log in here
Final Surprise Billing Rules Seek to Provide Fairer Price Dispute Resolution
Revised final rule essentially disarms the threat of insurers having the advantage in out-of-network price disputes.
Already a member? Log in here
CMS Proposes Significant Increases to CLIA Fees
While the rule is not yet final, it’s likely that labs will have to pay more in direct CLIA compliance expenses, starting in October.
Surprise Billing Rules Would Give Private Health Plans Advantage in Disputes
The way the No Surprises Act is implemented would essentially allow private health plans to set out-of-network rates in billing disputes.
Already a member? Log in here
Malpractice Premiums Rise but Medicare Reimbursement Doesn’t
...
Already a member? Log in here
Medicare to Cover Over-the-Counter COVID-19 Tests
...
Already a member? Log in here
CMS Restores Medicare Coverage of Certain Genetic Thyroid Cancer Tests
...
Already a member? Log in here
Blue Cross Blue Shield Sues National Lab for COVID-19 Test Price Gouging
...
Already a member? Log in here
Medicare Expands Coverage for CTC Tests
...
Already a member? Log in here
Labs and Payors Take Their COVID-19 Test Reimbursement Feud to Court
...
Already a member? Log in here
Labs Sue National Insurers for Not Reimbursing COVID-19 Testing Claims
...
Already a member? Log in here